Thursday, June 6, 2019

Alembic Pharma gains 1% after receiving approval for Carbidopa, Levodopa extended-release tablets USP

The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Sinemet CR Tablets, 25 mg/100 mg and 50 mg/200 mg, of Merck Sharp & Dohme Corp.

from India Infoline News Service http://bit.ly/2Wqg3xb

No comments:

Post a Comment